Regulatory S16 Ep43: FDA Approval Insights: Rucaparib for BRCA Mutation-Associated mCRPC: With David Morris, MD, FACS; and Alan H. Bryce, MD OncLive PodcastWelcome to OncLive On Air !RegulatoryOncologyRead full story pharminent March 31, 2026 (Last updated: April 1, 2026) OncLive Podcast Welcome to OncLive On Air ! RegulatoryOncologyRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Novo hits back at rivals with cut-price Wegovy subscriptionsNext: NHS to offer Wegovy to a million more people in England Related Stories Regulatory FDA approves MSD’s Keytruda combinations for MIBC pharminent July 13, 2026 Regulatory FDA freezes CRL trove as ‘radical transparency’ push hits speedbump pharminent July 9, 2026 Regulatory UK first in Europe to clear Boehringer’s IPF drug Jascayd pharminent July 9, 2026
